Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide Aerosol vs Budesonide Aerosol in Asthma Maintenance (Phase III)
CTR20160400Phase 3Completed
- Sponsor
- Beijing Rundekang Pharmaceutical Technology
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in asthma, sponsored by Beijing Rundekang Pharmaceutical Technology. Started Jul 2016; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20160400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160400.